MTSR
HIGH Impact
MTSR
Pfizer Completes Acquisition of Metsera, Inc.
|
8-K
Summary
On November 13, 2025, Pfizer Inc. completed its acquisition of Metsera, Inc. through a merger. As a result, Metsera, Inc.'s common stock ceased trading on Nasdaq and was delisted. The board of directors of Metsera, Inc. resigned, and new directors from Pfizer's subsidiary were appointed. Additionally, Pfizer issued contingent value rights to certain shareholders based on the achievement of specified milestones related to the development of Metsera's products.
Profitelligence Alerts
Get alerts for MTSR
Be first to know when MTSR files with the SEC.
Filing Categories
M&A Transaction
Partial Buyout
Voluntary Delisting
Transfer of Listing
Changes in Control of Registrant
Board Member Departure
Board Member Appointed
Convertible Notes Offering
Advertisement
Official SEC Documents
MTSR Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings
Advertisement